2020 ASCO Virtual Direct™ Highlights

 

GI
10:35

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on mCRC: Is T-DXd a New Treatment Option for Patients With Advanced HER2+ Disease?

FEATURING Arturo Loaiza-Bonilla
  • 72 views
  • October 27, 2020
09:35

2020 ASCO Virtual Direct™ Highlights

2020 Update on Esophagogastric Cancers: Did T-DXd Demonstrate Meaningful Clinical Improvements in ORR and OS vs. SoC Chemo in HER2+ Advanced Gastric/GEJ Cancer? Does the Addition of Ramucirumab to Perioperative FLOT Improve R0-resection Rates?

FEATURING Daniel Lin
  • 270 views
  • August 13, 2020
  • 2
05:00

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Pancreatic Cancer: Perioperative Chemotherapy + mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel - Which Option Provides More Benefit for Resectable Pancreatic Ductal Adenocarcinoma?

FEATURING Daniel Lin
  • 18 views
  • August 13, 2020
09:51

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HCC: Does Treatment With a Single, Priming Dose of Tremelimumab + Durvalumab Achieve Longest Median Survival in aHCC?

FEATURING Daniel Lin
  • 143 views
  • August 6, 2020
12:28

2020 ASCO Virtual Direct™ Highlights

2020 ASCO mRCC Highlights: Does the Updated KEYNOTE-426 Analysis Support Pembrolizumab + Axitinib Superiority Over Sunitinib? Does Tumor Shrinkage Correlate With OS?

FEATURING Manojkumar Bupathi
  • 48 views
  • August 6, 2020